EV/EBITDA
-0.88
+0.08+8.33%
Wed, 26 Feb 2025 21:07:57 GMT
Summary
- As of February 27, 2025, SAGE EV/EBITDA is -0.88, with a rise of +0.08 (+8.33%) during the most recent trading day.
- Over the past year, SAGE EV/EBITDA has increased by +1.45 (+62.23%).
- SAGE EV/EBITDA is now -113.75% below its all-time high of 6.40.
Performance
SAGE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SAGE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +8.3% | -8.1% | -6.9% |
| 1 m1 month | +3.3% | -3.4% | -3.0% |
| 3 m3 months | -22.2% | +36.3% | +20.9% |
| 6 m6 months | +3.3% | -11.1% | -15.3% |
| ytdytd | -37.5% | +37.0% | +29.1% |
| 1 y1 year | +62.2% | -71.5% | -68.5% |
| 5 y5 years | +80.7% | -88.7% | -89.0% |
SAGE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -1.00 | +12.0% | |
| 3 m | 3-month | -0.56 | -57.1% | -1.05 | +16.2% |
| 6 m | 6-month | -0.56 | -57.1% | -1.18 | +25.4% |
| 1 y | 1-year | -0.56 | -57.1% | -2.42 | +63.6% |
| 3 y | 3-year | -0.56 | -57.1% | -5.82 | +84.9% |
| 5 y | 5-year | 6.40 | -113.8% | -8.59 | +89.8% |
| alltime | all time | 6.40 | -113.8% | -52.31 | +98.3% |
Sage Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.88(+37.5%) |
| 2024 | -0.64(-72.2%) |
| 2023 | -2.30(-39.6%) |
| 2022 | -3.81(-22.1%) |
| 2021 | -4.89(-189.9%) |
| 2020 | 5.44(-205.0%) |
| Date | Value |
|---|---|
| 2019 | -5.18(-52.8%) |
| 2018 | -10.97(-54.8%) |
| 2017 | -24.25(+123.9%) |
| 2016 | -10.83(-31.5%) |
| 2015 | -15.80(-34.1%) |
| 2014 | -23.99 |
FAQ
- What is Sage Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Sage Therapeutics?
- What is SAGE EV/EBITDA year-to-date change?
- What is Sage Therapeutics EV/EBITDA year-on-year change?
What is Sage Therapeutics EV/EBITDA?
The current EV/EBITDA of SAGE is -0.88
What is the all time high EV/EBITDA for Sage Therapeutics?
Sage Therapeutics all-time high EV/EBITDA is 6.40
What is SAGE EV/EBITDA year-to-date change?
Sage Therapeutics EV/EBITDA has changed by -0.24 (-37.50%) since the beginning of the year
What is Sage Therapeutics EV/EBITDA year-on-year change?
Over the past year, SAGE EV/EBITDA has changed by +1.45 (+62.23%)